Breaking Down Avicopter Plc Financial Health: Key Insights for Investors

Breaking Down Avicopter Plc Financial Health: Key Insights for Investors

CN | Industrials | Aerospace & Defense | SHH

Avicopter Plc (600038.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Avicopter Plc (600038.SS) presents a compelling - and mixed - financial picture: while Q1 2025 revenue plunged 30% to CNY 2.38 billion due to reduced deliveries, trailing twelve-month revenue as of March 31, 2025, still rose 7.82% to CNY 28.77 billion after a CNY 29.77 billion 2024 full-year (11.93% growth), and the company targets CNY 30.2 billion in revenue for 2025; profitability shows a Q3 2025 net profit jump of 51.33% to CNY 90.43 million with TTM net income of CNY 571.32 million (net margin 2.08%, operating margin 5.63%, gross margin 10.00%, EPS TTM CNY 0.70 and P/E ~50), balance-sheet metrics include market cap CNY 29.80 billion and enterprise value CNY 24.64 billion, assets of CNY 53.0 billion against liabilities of CNY 35.6 billion, cash and short-term investments of CNY 8.54 billion and a conservative debt-to-equity of 27.4% but a troubling interest coverage of -26.9; liquidity and solvency flags include a current ratio of 1.46, quick ratio 0.86, operating cash flow of -CNY 9.02 billion for the first nine months of 2025 (improved 21.21% YoY), net cash of CNY 3.61 billion, Altman Z-Score 1.5 and Piotroski F-Score 6; valuation multiples show trailing P/E 51.16, forward P/E 44.38, P/S 1.06, P/B 1.68, EV/EBITDA 27.04 and analyst 12‑month target CNY 45.50 (range CNY 40-51) even as the share dropped 5.9% in the past week - for investors weighing risk versus growth (including a dominant domestic rotary-wing position, import-substitution tailwinds, and an analyst consensus of "Strong Buy"), the detailed metrics below will be essential.

Avicopter Plc (600038.SS) Revenue Analysis

Avicopter Plc reported mixed top-line signals across recent reporting periods. Q1 2025 revenue declined 30% year-over-year to CNY 2.38 billion, primarily driven by a reduction in product deliveries. Despite that near-term weakness, trailing twelve months (TTM) revenue as of March 31, 2025, was CNY 28.77 billion, representing a 7.82% increase versus the prior year. The company's full-year 2024 revenue was CNY 29.77 billion, an 11.93% increase over 2023.
  • Q1 2025 revenue: CNY 2.38 billion (-30% YoY)
  • TTM revenue (as of 2025-03-31): CNY 28.77 billion (+7.82% YoY)
  • FY 2024 revenue: CNY 29.77 billion (+11.93% YoY)
  • Primary cause of Q1 2025 decline: fewer product deliveries
  • Workforce: 13,935 employees; revenue per employee ≈ CNY 2.06 million
Period Revenue (CNY bn) YoY Change Notes
Q1 2024 3.40 - Baseline quarter for Q1 YoY comparison
Q1 2025 2.38 -30% Delivery-driven decline
FY 2024 29.77 +11.93% Annual growth vs 2023
TTM (to 2025-03-31) 28.77 +7.82% Shows trailing momentum despite Q1 dip
Employees 13,935 - Revenue per employee ≈ CNY 2.06 million
  • Interpretation: the large Q1 drop is material but the TTM and FY 2024 figures show underlying revenue expansion over the past year.
  • Key monitoring items for investors: delivery schedules, order book evolution, and quarterly revenue recovery trends.
Exploring Avicopter Plc Investor Profile: Who's Buying and Why?

Avicopter Plc (600038.SS) - Profitability Metrics

Key profitability indicators for Avicopter Plc (600038.SS) show mixed but improving performance through Q3 2025 and the trailing twelve months (TTM) ended March 31, 2025.

  • Q3 2025 net profit attributable to shareholders: CNY 90.43 million (↑ 51.33% YoY).
  • TTM net income (as of 2025-03-31): CNY 571.32 million; net profit margin: 2.08%.
  • TTM operating margin: 5.63%, indicating relatively efficient operating cost control.
  • Gross profit margin: 10.00%, reflecting moderate core profitability.
  • Return on equity (ROE): 2.73%.
  • TTM EPS: CNY 0.70; TTM P/E ratio: 50.06.
Metric Value Period / Note
Net profit attributable CNY 90.43 million Q3 2025 (↑51.33% YoY)
TTM Net income CNY 571.32 million As of 2025-03-31
Net profit margin 2.08% TTM
Operating margin 5.63% TTM
Gross profit margin 10.00% TTM
ROE 2.73% TTM
EPS (TTM) CNY 0.70 TTM
P/E ratio 50.06 TTM market multiple

Implications for investors:

  • Strong YoY net profit growth in Q3 2025 (+51.33%) signals recent operational or demand improvements driving near-term earnings acceleration.
  • Gross margin at 10% and operating margin at 5.63% indicate room for margin expansion through higher sales mix or further cost efficiencies.
  • Net margin of 2.08% and ROE of 2.73% remain modest, suggesting capital efficiency and bottom-line conversion are areas for improvement relative to global peers.
  • EPS of CNY 0.70 with a P/E of 50.06 implies market is pricing in high future growth or expects continued margin improvement; valuation is elevated versus earnings today.

For context on corporate direction that may affect future profitability, see: Mission Statement, Vision, & Core Values (2026) of Avicopter Plc.

Avicopter Plc (600038.SS) - Debt vs. Equity Structure

Avicopter's capital structure shows a conservative leverage stance on headline metrics but with operational stress reflected in coverage ratios. Key balance-sheet and market-value figures:
  • Market capitalization: CNY 29.80 billion (as of 17 Oct 2025)
  • Enterprise value (EV): CNY 24.64 billion
  • Total assets: CNY 53.0 billion
  • Total liabilities: CNY 35.6 billion
  • Equity (book value): CNY 17.36 billion; book value per share: CNY 21.04
  • Debt-to-equity ratio: 27.4%
  • Cash & short-term investments: CNY 8.54 billion
  • Interest coverage ratio: -26.9
Metric Amount (CNY) Comment
Market Cap 29,800,000,000 Market value of equity
Enterprise Value 24,640,000,000 EV slightly below market cap (net cash effect)
Total Assets 53,000,000,000 Asset base supporting operations
Total Liabilities 35,600,000,000 Includes short- and long-term obligations
Equity (Book Value) 17,360,000,000 Net assets attributable to shareholders
Book Value per Share 21.04 Accounting value per share
Debt-to-Equity Ratio 27.4% Conservative leverage versus peers
Cash & Short-term Investments 8,540,000,000 Liquidity buffer for near-term needs
Interest Coverage Ratio -26.9 Operating income insufficient to cover interest
  • Balance-sheet implication: With liabilities (CNY 35.6bn) notably above equity (CNY 17.36bn), the firm carries a meaningful claims gap funded by both debt and other liabilities, but the modest debt-to-equity ratio (27.4%) indicates much of liabilities may be non-debt or operating in nature.
  • Liquidity profile: Cash & short-term investments of CNY 8.54bn represent a significant cushion (≈49% of equity), supporting near-term obligations and operational flexibility.
  • Profitability stress: The negative interest coverage ratio (-26.9) signals operating losses or very low operating income relative to interest expense; this is a red flag for debt-servicing capacity despite available cash.
  • Market vs. book: Market cap (CNY 29.80bn) exceeds book equity (CNY 17.36bn), implying market premiums for future earnings or intangible value not captured on the balance sheet.
Mission Statement, Vision, & Core Values (2026) of Avicopter Plc.

Avicopter Plc (600038.SS) - Liquidity and Solvency

Avicopter Plc shows mixed liquidity signals: a current ratio of 1.46 indicates the company can cover short-term liabilities with its assets, while a quick ratio of 0.86 highlights potential strain meeting immediate obligations without relying on inventory. Operating cash flow for the first nine months of 2025 improved by 21.21% year-over-year but remained negative at -CNY 9.02 billion, offset in part by a net cash position of CNY 3.61 billion that provides a short-term buffer. Solvency and distress indicators raise caution: an Altman Z-Score of 1.5 points to higher bankruptcy risk versus peers, while a Piotroski F-Score of 6 indicates moderate financial strength and some operational improvements.
  • Current ratio: 1.46 - adequate short-term coverage.
  • Quick ratio: 0.86 - potential liquidity squeeze without inventory sales.
  • Operating cash flow (9M 2025): -CNY 9.02 billion, improved 21.21% YoY.
  • Net cash position: CNY 3.61 billion - liquidity cushion.
  • Altman Z-Score: 1.5 - elevated bankruptcy risk.
  • Piotroski F-Score: 6 - moderate financial strength.
Metric Value Comment
Current Ratio 1.46 Can cover short-term liabilities with assets
Quick Ratio 0.86 Below 1.0 - reliance on inventory to meet obligations
Operating Cash Flow (9M 2025) -CNY 9.02 billion 21.21% YoY improvement but still negative
Net Cash Position CNY 3.61 billion Provides short-term liquidity buffer
Altman Z-Score 1.5 Signals higher risk of distress vs industry
Piotroski F-Score 6 Moderate financial health and operational improvements
Key near-term considerations for investors include working capital management (given the quick ratio < 1), the path to sustained positive operating cash flow beyond the 21.21% improvement, and leverage/credit access given the Altman Z-Score. For deeper context on ownership and investor activity, see: Exploring Avicopter Plc Investor Profile: Who's Buying and Why?

Avicopter Plc (600038.SS) - Valuation Analysis

Avicopter Plc (600038.SS) currently trades at elevated multiples reflecting growth expectations and a premium relative to peers. Key market-implied valuations and analyst targets give investors a clear snapshot of how the market prices future cash flows and current asset base.
Metric Value Comment
Trailing P/E 51.16 High earnings multiple
Forward P/E 44.38 Market anticipates EPS growth
Price-to-Sales (P/S) 1.06 Near 1x revenue valuation
Price-to-Book (P/B) 1.68 Premium to book value
EV/EBITDA 27.04 Significant premium to cash operating earnings
EV/Sales 0.94 Enterprise value slightly below 1x revenue
Market Capitalization CNY 29.80 billion As of Oct 17, 2025; +2.16% YoY
Analyst 12‑month Price Target (consensus) CNY 45.50 Range: CNY 40 - CNY 51
  • High trailing P/E (51.16) vs forward P/E (44.38) indicates analysts expect earnings growth but the stock already prices substantial improvement.
  • EV/EBITDA of 27.04 signals investors are paying a premium for operating earnings - monitor margin expansion and capex conversion to justify this multiple.
  • P/S (1.06) and EV/Sales (0.94) show revenue is valued roughly at par with enterprise value, suggesting revenue growth is a primary value driver.
  • P/B at 1.68 implies modest premium to book; useful when assessing downside protection in stressed scenarios.
Valuation sensitivities to watch:
  • EPS trajectory vs the implied growth baked into forward P/E (44.38).
  • EBITDA margin recovery or deterioration, given the high EV/EBITDA (27.04).
  • Revenue growth consistency to support P/S ~1 and the consensus price target band (CNY 40-51).
For further investor-context analysis, see: Exploring Avicopter Plc Investor Profile: Who's Buying and Why?

Avicopter Plc (600038.SS) - Risk Factors

Key quantitative red flags for Avicopter Plc (600038.SS) indicate mixed financial health and potential near-term liquidity and solvency concerns that investors should weigh carefully.

Metric Value Interpretation
Interest Coverage Ratio Negative Insufficient operating income to cover interest expenses
Altman Z-Score 1.5 Elevated bankruptcy risk vs. healthy firm benchmark (>2.99)
Share Price (1-week change) -5.9% Recent volatility; potential market concern or profit-taking
Piotroski F-Score 6 Moderate financial strength; room for improvement
Debt-to-Equity Ratio 27.4% Conservative leverage profile
Quick Ratio 0.86 Potential difficulty meeting immediate liabilities without inventory sales
  • Negative interest coverage: operating earnings insufficient to cover interest-raises default risk if earnings do not stabilize or if interest costs rise.
  • Altman Z-Score at 1.5: statistically closer to distress zone; historically associated with higher probability of bankruptcy than industry peers.
  • One-week share price decline (-5.9%): short-term market sentiment is weak; could reflect earnings worries, sector pressure, or broader market moves.
  • Piotroski F-Score = 6: while not poor, this midpoint score signals that profitability, leverage, liquidity or efficiency improvements are needed to strengthen fundamentals.
  • Debt-to-equity 27.4%: conservative capital structure reduces refinancing risk but may limit growth if management avoids accretive borrowing.
  • Quick ratio 0.86: less than 1.0 implies potential reliance on inventory conversion or external financing to meet near-term obligations.

Investor considerations and tactical questions to ask management or model:

  • What is the root cause of negative interest coverage-temporary earnings weakness or structural margin compression?
  • Are there contingency plans (asset sales, covenant waivers, refinancing) to address shortfalls implied by the quick ratio and interest coverage?
  • How does management plan to improve the Piotroski F-Score components (profitability, leverage, liquidity, efficiency)?
  • Given the conservative debt-to-equity ratio, would management consider targeted, low-cost leverage to fund growth without materially increasing risk?
  • Monitor market reaction to upcoming earnings, guidance, or macro developments given the recent -5.9% price move.

Further context on investor base and activity can be explored here: Exploring Avicopter Plc Investor Profile: Who's Buying and Why?

Avicopter Plc (600038.SS) - Growth Opportunities

  • Management projects revenue of CNY 30.2 billion in 2025 with net profit attributable to the parent company of CNY 604 million, reflecting targeted mid‑to‑high single‑digit to double‑digit top‑line expansion driven by both military and expanding civil sales.
  • Avicopter maintains a dominant position in China's rotary‑wing aircraft segment supported by state‑backed procurement programs that underpin baseline defense demand.
  • The company is progressively expanding into commercial and utility applications (emergency medical services, offshore transport, law enforcement, and tourism), diversifying revenue streams beyond defense contracts.
  • Integrated manufacturing-from key component production to final assembly-strengthens vertical control, cost capture, and alignment with national aerospace industrialization policies.
  • Import substitution initiatives create a sizable addressable market as domestic platforms replace foreign models in government and civil fleets.
  • Analyst consensus rates the stock as a 'Strong Buy,' indicating favorable market sentiment and expectations of sustained operational scaling.
Metric 2025 Guidance / Position Relevance to Growth
Revenue CNY 30.2 billion Scale needed to amortize R&D and manufacturing fixed costs; expands cash flow potential
Net profit attributable to parent CNY 604 million Profitability signal as civil revenue mix grows
Market position Leading rotary‑wing share in China Staple demand via defense procurement; leverage for aftermarket and civilian sales
Product diversification Military → Commercial/Utility Reduces single‑buyer concentration risk; opens higher‑volume civil channels
Manufacturing model Integrated (components → assembly) Supports cost control, quality, and quicker ramp for new models
Strategic tailwind Import substitution & state policy support Improves domestic capture rates and long‑term demand visibility
  • Key levers for realizing 2025 targets:
    • Scaling civil model certifications and after‑sales network to convert defense engineering into commercial volumes.
    • Optimizing supply chain to reduce unit cost and protect margins amid higher production.
    • Targeted partnerships and localized content to accelerate import substitution wins within state procurement frameworks.
  • Risks to monitor:
    • Certification timelines for civil variants and pace of commercial order flow.
    • Competitive pressure from other domestic OEMs and potential technology gaps for high‑end mission profiles.
    • Dependence on government procurement cadence in the near term.
Mission Statement, Vision, & Core Values (2026) of Avicopter Plc.

DCF model

Avicopter Plc (600038.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.